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ackground & Aims: Digestive and liver diseases are
ssociated with substantial morbidity and mortality in
he United States. Statistics about the incidence, preva-
ence, mortality, and resource utilization of digestive and
iver diseases in the United States may be cumbersome
o obtain because they are scattered in multiple
ources. These data may be useful for policy makers,
rant applicants, and authors. Methods: Data on the
ost common gastrointestinal and liver diseases were
ollected from large publicly available national data-
ases. Information was collected on inpatient and out-
atient gastrointestinal complaints and diagnoses, gas-
rointestinal cancers, and deaths from common liver
iseases. Results: The leading gastrointestinal com-
laint prompting an outpatient visit is abdominal pain,
ith 12.2 million annual visits, followed by diarrhea,
ausea, and vomiting. Abdominal pain is the leading
utpatient gastrointestinal diagnosis, accounting for 5.2
illion visits annually, followed by gastroesophageal
eflux disease, with 4.5 million visits. Gallstone disease
s the most common inpatient diagnosis, with 262,411
ospitalizations and a median inpatient charge of
11,584. Colorectal cancer is the most common gastro-
ntestinal cause of death and is the most common
astrointestinal cancer, with an incidence of 54 per
00,000. Among gastrointestinal cancers, primary liver
ancer had the highest increase in incidence from 1992
o 2000. Conclusions: Gastrointestinal and liver dis-
ases are associated with significant outpatient and
npatient healthcare utilization. Following trends in utili-
ation is important for determining allocation of re-
ources for health care and research.
igestive and liver diseases are common in the
United States. They affect large numbers of indi-
iduals and exact a considerable financial and social
urden. These diseases are associated with frequent phy-
ician visits and hospitalizations and are sometimes fatal.
Although data on digestive and liver conditions are
ollected on a regular basis, they are sometimes difficult
o locate. Moreover, previous compilations of statistics on
igestive diseases are lengthy or do not provide data on
utpatients.1,2 The American Gastroenterological Asso-iation publication, The Burden of Gastrointestinal Diseases,
s a comprehensive report, but it is lengthy and has not
een recently updated.1 Herein, we provide a concise
escription of frequently used statistics displayed in ta-
les comparing common gastrointestinal diagnoses. A
ublication on selected digestive diseases in the United
tates focused mostly on costs and does not provide data
n symptoms and diagnoses for outpatient visits or on
he incidence and prevalence of gastrointestinal cancers.2
Our goals were to collect and report the most recent
tatistics on deaths, symptoms, physician visits, and hos-
italizations for common digestive and liver diseases.
hese data are unique because they are population based
nd are gathered from large national databases. This
nformation should be a valuable reference for authors,
rant applicants, funding agencies, and policy makers.
mportantly, the data are likely to raise questions and
ead to future research.
Materials and Methods
Gastrointestinal Causes of Death
Data on the leading causes of death were obtained from
ortality tables from the Division of Vital Statistics, National
enter for Health Statistics (Table 1). A total of 2,403,351
eaths in the United States were reported during the year
000. Causes of death were reported on the basis of the 10th
evision of the International Classification of Diseases (ICD-10;
992). In constructing these tables, the underlying cause of
eath is ascertained from death certificate data and then coded
ccording to the most recent revision of ICD-10 codes. ICD-10
odes were published by the World Health Organization in
992 and have been used for coding and classifying causes of
eath since 1999. ICD-10 codes differ from ICD-9 codes in
ome ways, although the overall content is similar. ICD-10 has
lphanumeric categories rather than numeric categories and
Abbreviations used in this paper: ICD, International Classification of
iseases; NAMCS, National Ambulatory Medical Care Survey; NIS,
ationwide Inpatient Sample; SEER, Surveillance, Epidemiology, and
nd Results.

























































the National Ambulatory Medical Care Survey 2000.
May 2004 DIGESTIVE AND LIVER DISEASES STATISTICS 1449as almost twice as many categories as ICD-9. Therefore, data
resented with ICD-9 codes cannot be directly compared with
ata presented as ICD-10 codes because of differences in the
erms used for specific diagnoses. Of note, gastrointestinal
alignancies have not been subclassified by histological subtype.
Gastrointestinal Symptoms and Diagnoses
The leading gastrointestinal symptoms prompting an
utpatient clinic visit were estimated from a random sample of
7,369 patient visits to 1388 physicians participating in the
ational Ambulatory Medical Care Survey (NAMCS) 2000
Tables 2 and 3). This survey was also used to estimate the
eading physician diagnoses for outpatient clinic visits. The
AMCS was a national survey designed to provide informa-
ion about the use of ambulatory care services in the United
tates. Findings were based on a sample of visits to non–
ederally employed office-based physicians who were primarily
ngaged in direct patient care. Each physician was randomly
ssigned to a 1-week reporting period. During that period,
hysicians, office staff, or both recorded data from a random
ample of visits. Data included patients’ symptoms and phy-
icians’ diagnoses. Patients were asked to provide, in their own
ords, their primary complaint, symptom, or other reason for
he office visit. Patients provided their complaint, and after the
ffice visit, physicians or staff were asked to code the primary
iagnosis for the visit and the primary complaint. In 2000, a
otal of 27,369 patient record forms were received from the
388 physicians who participated in the NAMCS. To obtain
ational estimates from the sample, an inflation factor called
able 1. Leading 20 Gastrointestinal Causes of Death in the
Rank Cause of death No.
1 Colorectal/anal cancer
2 Pancreatic cancer
3 Fibrosis/cirrhosis of liver and hepatic
failure not otherwise specified




7 Alcoholic liver disease
8 Vascular disorders of the intestine
9 Gastrointestinal hemorrhage, unspecified
10 Paralytic ileus and intestinal obstruction
11 Ulcers (gastric/duodenal/peptic)
12 Acute hepatitis C
13 Diverticular disease
14 Acute pancreatitis
15 Malignant neoplasms of the gallbladder
16 Biliary tract cancer
17 Peritonitis
18 Perforation of intestine (nontraumatic)
19 Cholecystitis
20 Clostridium difficile enterocolitis
OTE. Source: National Center for Health Statistics Web site—mo
ctober 7, 2003.
Of a total of 2,403,351 deaths in 2000.United States, 2000
of deathsa ICD-10 codes
57,477 C18.0–C18.9, C19, C20, C21.0–C21.2, C21.8
29,332 C25.0–C25.4, C25.8–C25.9
14,003 K72.0–K72.1, K72.9, K74.0–K74.1, K74.3–K74.6







4504 K25.0–K25.1, K25.3–K25.7, K25.9, K26.0–K26.7,










rtality tables (http://www.cdc.gov/nchs/data/dvs/wktbli.pdf). Accessed:able 2. Leading Gastrointestinal Symptoms
Prompting an Outpatient Clinic Visit








eartburn and indigestion (dyspepsia) 1,824,043
onstipation 1,327,156
nal/rectal bleeding 1,260,644
lood in stool (melena) 1,179,224
ther, unspecified gastrointestinal symptoms 957,866
ecreased appetite 715,737
ifficulty swallowing (dysphagia) 676,421
nal/rectal pain 514,896
ther symptoms or changes in bowel function 466,803
aundice 431,410
bdominal distension, fullness, or swelling 384,877
bdominal mass or tumor 247,850
astrointestinal bleeding 229,729
nal/rectal swelling or mass 224,093
latulence 209,434
OTE. Source: National Ambulatory Medical Care Survey 2000
http://www.cdc.gov/nchs/nhcs.htm).
The total number of outpatient visits was estimated from a random

























1450 RUSSO ET AL. GASTROENTEROLOGY Vol. 126, No. 5atient visit weight was applied to estimate statistics for the
23,541,999 office visits made in the United States during the
ear 2000. Table 2 describes the leading patient complaints,
nd Table 3 lists the subsequent physician diagnosis.
Hospitalizations for Gastrointestinal
Disorders
Data on hospitalizations for gastrointestinal diseases
ere obtained from the Healthcare Costs Utilization Project
able 3. Leading Physician Diagnoses for Gastrointestinal Di
Rank Diagnosis
1 Abdominal pain




6 Irritable bowel syndrome
7 Hernias—noninguinal
8 Benign neoplasm of colon
9 Colorectal cancer
10 Inguinal hernia




15 Occult gastrointestinal blood loss
16 Acute or chronic hepatitis C
17 Crohn’s disease
18 Anal/rectal bleeding
19 Ulcerative colitis or proctitis
20 Gastric or duodenal ulcer
21 Abnormal liver scan
22 Cirrhosis
23 Melena
OTE. The total number of outpatient visits was estimated from a ran
he National Ambulatory Medical Care Survey 2000 (http://www.cdc.
The numbers of visits for the diagnoses below rank 10 were estimat
nreliable.





all diagnoses Diagnosis (ICD-9 code)
1 574 #35a
574.1 #43b
Cholelithiasis with acute cholecyst
(574); cholelithiasis with cholec
not elsewhere classifiable (574
2 20 Acute pancreatitis (577)
3 27 Acute appendicitis (540.9)
4 32 Diverticulitis of colon without hem
(562.11)
5 34 Noninfectious gastroenteritis (574
6 45 Gastrointestinal hemorrhage (578
7 56 Esophageal reflux (530.81)
8 61 Intestinal obstruction (560.9)
9 84 Diverticulosis with hemorrhage (56
OTE. Source: Healthcare Costs Utilization Project (http://hcup.ahrq
The individual ICD-9 code for cholelithiasis with acute cholecystitis
The individual ICD-9 code for cholelithiasis with cholecystitis not els
The number of deaths was too small for a stable estimate.Table 4). This project is composed of the Nationwide Inpa-
ient Sample (NIS), which is a unique and powerful database of
ospital inpatient stays. NIS contains all discharge data from
94 hospitals located in 28 States, approximating a 20%
tratified sample of US community hospitals with data from
pproximately 7.5 million hospital stays. NIS 2000 is a sample
f hospitals that comprise approximately 80% of all hospital
ischarges in the United States. NIS is the only national
ospital database with charge information on all patients,
ers in Outpatient Clinic Visits in the United States, 2000a






















20, 571.50, 571.60 419,021
10 401,602
sample of 27,369 patient visits to 1388 physicians participating in
nchs/nhcs.htm).
m weighting a small number of office encounters (30) and may be










262,411 2 11,584 0.6
210,188 4 9364 1.8
170,337 2 8525 —c
ge 155,407 4 9468 1.1
147,939 2 3990 0.3
115,355 3 7751 5
96,019 2 6712 —c
93,226 3 6479 3.1
) 68,292 3 7804 1.2
HCUPNet.asp).
and its rank among all diagnoses (#35).






























































































































May 2004 DIGESTIVE AND LIVER DISEASES STATISTICS 1451egardless of payer, including persons covered by Medicare,
edicaid, private insurance and the uninsured. In Table 4, the
eading gastrointestinal diagnoses (primary diagnosis) for hos-
italizations are provided. The diagnosis of cholecystitis was
ombined from 2 ICD-9 codes (cholelithiasis with acute cho-
ecystitis [574] and cholelithiasis with cholecystitis [574.1]) to
ccurately reflect the burden of disease from gallstones, because
hese diagnoses are very similar. The individual rankings are
rovided in the table.
Infectious Gastrointestinal Diseases and
Liver Diseases
Information on cases of infectious gastrointestinal dis-
ases was obtained from the Morbidity and Mortality Weekly
eport (Table 5). The 50 states, the District of Columbia, and
S territories report data on reportable diseases. Diseases that
re reportable and of interest to gastroenterologists are listed in
able 5. Data on reportable diseases are updated on a regular
asis with comparison made to the previous year. The data are
evised weekly and are subject to change. As additional infor-
ation becomes available, statistics are updated and revised.
Mortality From Liver and Biliary Diseases
Table 6 lists the mortality burden from the leading
iver diseases. Causes of death from selected liver diseases were
btained from the United States Department of Health and
uman Services, the Centers for Disease Control and Preven-
ion, the National Center for Health Statistics, the Office of
nalysis and Epidemiology, the Compressed Mortality File,
omputer tape, and the Centers for Disease Control and Pre-
ention WONDER online database. These sources are public
ecords with links to sites that collect population-based data
n human diseases. The Compressed Mortality File is a county-
evel national mortality and population database that spans
ecades; it is derived from US records of deaths (death certif-
cates) since 1979. Counts and rates of death can be obtained
y place of residence (US state and county), age (17 age
roups), race (white, black, and other), sex, year, and under-
ying cause of death (4-digit ICD code or group of codes).
eath rates based on counts of 20 or less (death count 20) are
agged as unreliable. A death rate based on fewer than 20
able 5. Number of Reported Cases of Infectious






cute hepatitis A 3767
cute hepatitis B 2767
nterohemorrhagic Escherichia coli 527
OTE. Source: Morbidity and Mortality Weekly Report Table II (part 2,
, 4, and 6), week ending May 17, 2003 (MMWR Morb Mortal Wkly
ep 2003;52:478–486 (http://www.cdc.gov/mmwr/).eaths has a relative SE of 23%, which is considered statis-
ically unreliable.
Gastrointestinal Cancer Rates
Information on cancer rates is based on data published
y the Surveillance, Epidemiology, and End Results (SEER)
rogram (http://seer.cancer.gov) of the National Cancer Insti-
ute (http://www.cancer.gov) (Table 7). The SEER program
ontains population-based information on cancer incidence and
urvival in the United States. It provides data collected and
ublished, from 1975, on cancer prevalence, incidence, and
ortality rates from 9 population-based cancer registries in-
luding the San Francisco/Oakland standard metropolitan sta-
istical area, Connecticut, Detroit (metropolitan), Hawaii,
owa, New Mexico, Seattle (Puget sound), Utah, and Atlanta
metropolitan). The SEER program uses a “first malignant
rimary only” method. The data include only the first malig-
ant tumor and count a person only once (i.e., the prevalence
f specific cancer sites adds up to the prevalence of all cancers
ombined). The reported prevalence rates for gastrointestinal
ancers (Table 7) include all alive patients who were diagnosed
ith gastrointestinal cancer before 2000. Once a case is
ounted, it will be included in the prevalence of the specific
iagnosis as long as the individual is alive, even if the indi-
idual was treated and cured (e.g., the patient underwent an
peration and the cancer was excised). In addition, the SEER
atabase counts only the first diagnosed primary cancer. Thus,
n individual case can be included only once and would not be
ounted again if a second primary cancer were diagnosed.
Discussion
The data presented in this article provide a com-
rehensive and contemporary summary of digestive and
iver disease in the United States. By compiling data
rom disparate sources, we provide a convenient resource
able 6. Causes of Death From Selected Liver Diseases in






iver cell carcinoma 4.5 12,383 C22
lcoholic liver disease 4.4 11,958 K70.0–K70.4, K70.9
cute hepatitis C 1.2 3181 B17.1
ile duct carcinoma 0.9 2552 C22.1
cute hepatitis B 0.3 703 B16, B16.0, B16.1,
B16.2, B17.0
hronic hepatitis C 0.2 582 B18.2
rimary biliary cirrhosis 0.2 414 K74.3
cute hepatitis A —a 134 B15, B15.0, B15.9
hronic hepatitis B —a 129 B18, B18.1
OTE. Source: United States Department of Health and Human Ser-
ices, Centers for Disease Control and Prevention (CDC), National
enter for Health Statistics, Office of Analysis and Epidemiology,
ompressed Mortality File, computer tape, and CDC WONDER online
atabase.









































































1452 RUSSO ET AL. GASTROENTEROLOGY Vol. 126, No. 5or researchers and health planners. In addition, statistics
an be periodically updated to identify trends in inci-
ence, prevalence, and mortality of diseases, and this may
ave implications for health policy.
A strength of the data assembled for this report is that
he data were population based and can be used to
alculate national statistics. In addition, the NAMCS
elies on trained interviewers who visited physicians
efore participation to instruct them how to complete
he forms. All medical coding and keying operations
ere subject to quality-control procedures.
The databases that we used in the report have their
imitations. For example, we used NAMCS to derive data
n symptoms and office diagnoses. In the NAMCS, only
isits to non–federally employed physicians are included,
nd therefore data do not apply to veterans and other
opulations that receive care within a self-contained
ystem. Encounters outside of the physician’s office, in-
luding telephone contact, house calls, hospital settings,
nd institutional settings, are not included. In addition,
stimates based on fewer than 30 records should be
onsidered unreliable. The NAMCS may overstate the
utpatient burden due to colorectal cancer because pa-
ients may be seen regularly for surveillance after treat-
ent compared with patients with gallstone disease, who
ay not be seen after cholecystectomy.
A limitation of mortality data is that trends in death
ates are difficult to establish because changes in coding
rom using ICD-9 codes to ICD-10 codes occurred in
999. Therefore, comparisons in mortality from before
nd after 1999 are difficult to perform. If comparisons are
o be made over time, it is important to be consistent in




all sites Cancer site




5 25 Liver and intrahepatic du
6 NA Gallbladder
OTE. Source: Surveillance, Epidemiology, and End Results (SEER) p
A, statistics not available.
The reported prevalence rates represent the estimated US cancer
egistries and January 1, 2000, US population estimates. These preva
he reported incidence rates represent the age-adjusted incidence pe
etween 1996 and 2000, from the 12 SEER registries.
Trends in SEER incidence and US mortality are reported by annual p
exes. The mortality trends are per 100,000 and are age-adjusted to
The reported mortality represents the US death rates per 100,000,
se data file (http://www.cdc.gov/nchs). The data are for the entire U
S standard population.
The annual percentage change is significantly different from zero (Poding and classifying diseases from year to year. For
xample, we found that the number of deaths from
lcoholic liver disease was much different from the num-
er of deaths from alcoholic cirrhosis. Consistency in
iagnosis and coding is necessary so that estimates accu-
ately reflect trends that may occur over time. In addi-
ion, misclassification of diagnoses may occur. For in-
tance, in 1999 and 2000 (Tables 1 and 6), more than
000 individuals are reported to have died from acute
epatitis C. These estimates are higher than expected
iven that fatal acute hepatitis C is rarely reported in the
iterature. One possible explanation is that these patients
ay have been misclassified or misdiagnosed and actually
ied from chronic hepatitis C.
Rates of reportable infectious diseases are published in
he Morbidity and Mortality Weekly Report. Data are de-
ived from state and local health departments, and there-
ore the accuracy of these rates is dependent on physicians
omplying with reporting guidelines. Statistics on infec-
ious gastrointestinal diseases may be underestimated if
ata on cases are missing or incomplete. In addition, the
umber of cases of infectious diseases may be underesti-
ated if the disease is asymptomatic, as is the case with
cute or chronic hepatitis C. Despite these limitations,
he Morbidity and Mortality Weekly Report provides valu-
ble information on the incidence of these diseases.
The SEER registry reports data on cancer prevalence.
atients diagnosed with cancer are considered prevalent
ases until death, even if they had an early-stage cancer
hat was considered cured by resection. Therefore, prev-
lence, in this case, includes patients who are living with
ancer (true prevalence) and patients who had cancer but







1,041,499 54.2 0.6 21.2 1.7d
59,527 9.1 1.3d 4.8 2.8d
23,534 11.1 0.4 10.5 0.1
21,528 4.5 0.3 4.3 0.6d
13,266 5.9 3.9d 4.5 2.1d
5749 1.2 2.6d 0.8 2.4d
m (www.seer.cancer.gov).
lence counts based on the 2000 cancer prevalence from the SEER
s are for all ages, races/ethnicities, sexes, and diseases diagnosed.
,000 for all ages, races/ethnicities, sexes, and diseases diagnosed
tage change for 1992–2000 and for all ages, races/ethnicities, and
2000 US standard population.
on data provided by the National Center for Health Statistics public



































May 2004 DIGESTIVE AND LIVER DISEASES STATISTICS 1453re now cured. For instance, the SEER registry captures
ata from 12 states, and statistics on the national cancer
urden are extrapolated to the entire US population.
ecause the SEER registry collects data from selected
ites, calculations based on SEER registry data may not
ruly reflect cancer rates in the United States because of
ifferences in cancer rates in geographic areas not in-
luded in SEER.
The first step in decreasing the burden of digestive and
iver diseases is to improve our understanding of the
umber of cases and the impact. It is to be hoped that the
nformation included in this report will help to focus
ebate and research on the more common diseases and
ymptoms that bring patients to physicians. Success will
e measured by decreases in incidence, prevalence, and
ost when the data are next updated.References
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